glp 1 and alcohol GLP-1 Anti-Obesity Rx and Substance Use Disorders Frontiers | The therapeutic potential
Description
The recent US tariff policies implemented in April 2025 could have specific implications for the GLP-1 Receptor Agonist Market
Right now, that means considering GLP-1 medications and hormone therapy as part of a comprehensive, medically sound strategy
Protect from light, moisture, and heat, and avoid repeated freeze-thaw cycles
GLP-1 receptor agonists like Ozempic are not for everyone
In Canada, the baseline risk of major birth defects is 3-5%
